SUZHOU
Onkocare has established a research platform that integrates algorithm construction, biological data storage, tumor marker development, and experimental preliminary testing.。
Onkocare has a high level of research in high-performance biological big data computing and storage clusters, deeply participates in multiple major scientific research projects, and maintains industry university research cooperation with multiple research institutes at home and abroad, promoting the research and development of cancer early screening and diagnosis technology and clinical application transformation.
DNA methylation hypersensitivity linked detection technology
One of the few technologies in the world that achieve multiple detection schemes for trace DNA methylation
DNA methylation hypersensitivity linked detection technology is a detection method developed independently by Onkocare Life Technology based on the principle of DNA biomarkers for early screening of DNA methylation in cancer. It is the world's first to achieve multiple ultra high cost-effective detection solutions for trace DNA methylation.

-
Unbiased cfDNA methylation sequencing technology
Unbiased cfDNA methylation sequencing technology is mainly used to analyze methylation information in cfDNA that is free outside the cell
-
NGS Multi omics Joint Detection Technology
NGS multi omics joint detection technology is a high-throughput sequencing technology
-
Fluorescence quantitative PCR technology
Fluorescence quantitative PCR technology is mainly based on DNA amplification and fluorescence probe technology
-
Machine learning algorithm technology
Machine learning algorithm technology is an artificial intelligence technology that learns data features and patterns through algorithms
-
Non invasive and convenient
In vitro diagnosis
-
Highly sensitive
No missed diagnosis
-
High specificity
No misjudgment
-
Multiple types of cancer, may originate from lakes
Identify the location of the lesion
-
High throughput
Serving a massive audience
-
low cost
HP Inspection